Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $4.61 $6.39 Thursday, 9th May 2024 AFMD stock ended at $5.24. This is 0.0956% more than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 2.82% from a day low at $5.14 to a day high of $5.28.
90 days $4.25 $7.24
52 weeks $2.24 $11.10

Historical Affimed N.V. prices

Date Open High Low Close Volume
May 31, 2016 $35.60 $35.60 $35.60 $35.60 12 542
May 27, 2016 $33.70 $33.70 $33.70 $33.70 6 618
May 26, 2016 $34.00 $34.00 $34.00 $34.00 7 921
May 25, 2016 $36.40 $36.40 $36.40 $36.40 13 210
May 24, 2016 $35.90 $35.90 $35.90 $35.90 17 050
May 23, 2016 $34.20 $34.20 $34.20 $34.20 10 196
May 20, 2016 $32.50 $32.50 $32.50 $32.50 21 795
May 19, 2016 $30.90 $30.90 $30.90 $30.90 32 425
May 18, 2016 $31.00 $31.00 $31.00 $31.00 22 619
May 17, 2016 $33.30 $33.30 $33.30 $33.30 12 756
May 16, 2016 $34.50 $34.50 $34.50 $34.50 11 386
May 13, 2016 $33.70 $33.70 $33.70 $33.70 14 981
May 12, 2016 $33.40 $33.40 $33.40 $33.40 21 035
May 11, 2016 $34.90 $34.90 $34.90 $34.90 15 718
May 10, 2016 $36.20 $36.20 $36.20 $36.20 15 654
May 09, 2016 $36.50 $36.50 $36.50 $36.50 11 525
May 06, 2016 $35.60 $35.60 $35.60 $35.60 16 876
May 05, 2016 $36.10 $36.10 $36.10 $36.10 15 764
May 04, 2016 $36.00 $36.00 $36.00 $36.00 29 519
May 03, 2016 $38.50 $38.50 $38.50 $38.50 19 109
May 02, 2016 $40.70 $40.70 $40.70 $40.70 13 582
Apr 29, 2016 $40.50 $40.50 $40.50 $40.50 18 139
Apr 28, 2016 $42.70 $42.70 $42.70 $42.70 14 812
Apr 27, 2016 $43.20 $43.20 $43.20 $43.20 21 294
Apr 26, 2016 $45.60 $45.60 $45.60 $45.60 23 670
Click to get the best stock tips daily for free!

About Affimed N.V.

Affimed N.V. Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in Phase I clinical trial for hodgkin lymphoma. The company is also developing AFM24, a tetravalent, bispec... AFMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT